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proved adherence, (4) more patients with stable positive 
outcomes after treatment and (5) fewer patients relapsing 
into harmful drinking. The aim of this paper is to discuss the 
rationale for the RESCueH programme, to present the stud-
ies and expected results.  © 2016 S. Karger AG, Basel 
 Introduction 
 Alcohol problems are often progressive and debilitat-
ing, and have recently been identified to be the overall most 
harmful drug, with heroin and cocaine in second and third 
place  [1] . The World Health Organization has reported ex-
cessive alcohol consumption to be the second most impor-
tant lifestyle factor (after tobacco use) affecting the overall 
disease burden in high-income countries  [2] . Alcohol is a 
significant cause of non-communicable diseases  [3] .
 Given the associated increased morbidity, alcohol 
problems represent a major economic burden for society. 
 Key Words 
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 Abstract 
 Excessive alcohol consumption is one of the most important 
lifestyle factors affecting the disease burden in the Western 
world. The results of treatment in daily practice are modest 
at best. The aim of the RESCueH programme is to develop 
and evaluate methods, which are as practice-near as possi-
ble, and therefore can be implemented quickly and easily in 
everyday clinical practice. It is the first clinical alcohol pro-
gramme to be transatlantic in scope, with implementation 
in treatment centers located in Denmark, Germany and the 
US. The RESCueH programme comprises 5 randomized con-
trolled trials, and the studies can be expected to result in (1) 
more patients starting treatment in specialized outpatient 
clinics, (2) a greater number of elderly patients being treated, 
(3) increased patient motivation for treatment and thus im-
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The Alcohol in Europe Report estimated that the direct 
costs associated with alcohol accounted for 1.3% of the 
European gross domestic product, while the indirect 
costs, such as loss of working-life years, are twice that  [4] . 
Costs related to alcohol dependence add up to EUR 
1,591–7,702 per patient in hospital costs alone  [5] .
 Despite the magnitude of the problems caused by al-
cohol use disorders (AUDs), current management and 
therapeutic strategies for patients with chronic or severe 
alcohol dependency either suffer from low effectiveness 
or are not implemented  [6, 7]. 
 Among people with mental disorders, the disparity in 
numbers between those who suffer and those who actu-
ally receive treatment is vast, with the largest treatment 
gap existing among people with alcohol dependence. In 
Europe, 92% of these potentially treatment-requiring pa-
tients are not offered treatment  [8] .
 In February 2011, the Lundbeck Foundation contacted 
leading researchers at the Unit of Clinical Alcohol Re-
search (UCAR) at the University of Southern Denmark 
with a view to support clinical alcohol research in 
 Denmark. After a meeting with the Foundation’s officials, 
a research group consisting of Danish, German and US 
alcohol researchers was established (RESCueH research 
team; online suppl. appendix I, see www.karger.com/
doi/10.1159/000447398).
 Over the next 2 years, the group met regularly; 5 stud-
ies were planned and protocols were prepared. The 5 
studies, described in a comprehensive research pro-
gramme operating under the acronym RESCueH, have 
the following objectives:
 The Relay Study: better recruitment of patients to 
treatment, as only a minority of alcohol-dependent drink-
ers currently receive treatment.
 The Elderly Study: individual treatments geared to in-
dividual needs, reflecting the heterogeneity of alcohol-
dependent patients.
 The Self-match Study: greater patient involvement in 
treatment, since active involvement in treatment decision 
processes is essential for compliance.
 The Cue Exposure Study: preventing relapse, as a re-
turn to harmful drinking is a common problem.
 The Healthy Lifestyle Study: encouraging a healthy 
lifestyle, which may improve compliance in treatment 
and prevent relapse.
 The research programme represents a collaboration 
involving psychiatry, psychology, biostatistics and health 
economics. In addition, it is the first transatlantic clinical 
alcohol programme to be implemented, spanning treat-
ment centers located in Denmark, Germany and the US. 
The programme encompasses outpatient treatment facil-
ities and somatic hospitals and will include 3,000  patients 
with AUDs. Online supplementary appendix I details the 
principal investigators, other research staff and the par-
ticipating  centers.
 Rationale 
 Is There a Need for Trials of New 
Non-Pharmacological Interventions? 
 There have been many well-conducted randomized 
controlled trials (RCTs) concerning treatment of AUDs. 
Several comprehensive reviews have shown that there are 
specific effects of several types of well-described behav-
ioral therapeutic interventions  [9–11] . Thus, there is a 
good basis for providing evidence-based treatments in 
daily practice. However, there is a significant gap between 
what research shows and the treatment given in daily 
practice  [7] . Moreover, the therapeutic strategies com-
monly used in specialized treatment institutions are often 
unsystematic, ineffective and insufficiently targeted to 
the specific needs of the broad and heterogenic group of 
alcohol-dependent patients  [12, 13] .
 But why is the same effect not achieved in everyday 
practice as in research programmes? A major reason is 
that RCTs do not include the same patient groups as 
those encountered in everyday practice  [14] . In RCTs, 
patients with medical conditions, mental disorders and 
a lack of compliance/motivation are often excluded 
from participation  [15] . This lack of inclusiveness means 
that only 20% of patients in the RCTs represent the pa-
tients typically encountered in daily practice  [14] . The 
therapists in routine treatment facilities meet precisely 
those patients who lack motivation and have medical 
and comorbid mental disorders or drug problems – fac-
tors that could have a negative impact on the effective-
ness of treatment. In consequence, therapists find that 
their results fail to match the research results, and this 
may inhibit the adoption of evidence-based treatments 
 [16] . It may also mean that politicians and administra-
tive decision-makers will be less likely to recommend 
and pay for evidence-based treatments when they fail to 
produce substantial improvements in treatment results 
in everyday practice.
 Another significant problem is that of achieving stan-
dardization of treatment and ensuring that therapists 
master it. For RCTs, manual-guided treatment is the 
norm. It is performed by highly trained therapists who 
receive regular supervision. The individual therapy ses-
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sions are videotaped and coded in order to ensure fidelity. 
However, it is not known whether the therapists’ exper-
tise is retained when these activities cease  [13] . The type 
of training received by the therapists in RCTs is often 
time-consuming and expensive, and it would be difficult 
to provide all therapists with this training in everyday life. 
Thus, it is unclear how the therapists’ competence can be 
ensured, given their varying degrees of educational back-
ground, and it is doubtful whether all of them can acquire 
and retain the expertise shared by therapists participating 
in RCTs  [6] .
 One last problem with the RCTs is the comprehensive 
analytical procedures at treatment initiation and at sub-
sequent follow-ups. In some studies, the analytical proce-
dure and the many follow-up interviews are virtually in-
terventions in themselves and may contribute to the blur-
ring of the active ingredients of the intervention under 
investigation.
 The RCT is the gold standard for the evaluation of new 
therapeutic interventions since, given its enrolment of 
well-defined patient groups, the high assurance that the 
treatment being investigated is actually delivered, the fact 
that analysis is based on detailed evaluation instruments 
and that any differences between the groups are believed 
to be causal, its design ensures a high degree of internal 
validity. RCTs are also known as efficacy trials and are, 
accordingly, implemented under optimal conditions with 
the aim of maximizing internal validity. This is in contrast 
to effectiveness trials, with their focus on everyday clinical 
situations  [17] .
 Methods 
 General Features of the RESCueH Design 
 The aim of the RESCueH programme is to develop and 
evaluate new non-pharmaceutical treatment methods 
that are as practice-near as possible and, hence, can rap-
idly and easily be implemented in everyday clinical prac-
tice. We have, therefore, chosen to conduct the studies as 
pragmatic RCTs, deploying methods from both RCT and 
naturalistic studies  [18] .
 In all the studies, the exclusion criteria are few, and 
comorbidity or co-medication is allowed. This means 
that the enrolled patients are representative of those treat-
ed in daily practice.
 The enrollees are randomized to the individual stud-
ies’ interventions and control groups. We have opted 
for randomization since conventional statistical meth-
ods generally fail to overcome confounding by indica-
tion  [19] . Such analyses are unable to control for con-
founders (e.g., the staff’s opinion as to which treatment 
should be offered to the individual patient), which may 
be critical to the outcome of a given intervention. RCTs 
take account of the unknown confounders since ran-
domization is expected to distribute potential con-
founders equally between intervention and control 
groups.
 The therapists participating in the studies are recruited 
from the outpatient clinics’ regular staff. There will be 
staff training as well as supervision of the individual in-
terventions.
 In most of the RESCueH studies (except the Elderly 
Study), the initial assessment is conducted by regular staff 
who are trained in the assessment instruments, and co-
ratings are carried out. Few follow-up interviews are car-
ried out.
 The interventions are simple and often the need for 
training is fairly limited. In several studies, we compare 
the new intervention with treatment as usual (TAU), 
which also has a treatment effect. This leads to a low effect 
size in the relevant studies, thereby increasing the need 
for the enrolment of many patients in order to establish 
an effect of the intervention. In light of this, we have cho-
sen to conduct several of the studies as multicenter stud-
ies, including 2 or more centers.
 In the Self-match Study, the Cue Exposure Study and 
the Healthy Lifestyle Study, the primary outcome is to re-
duce alcohol consumption, which as a minimum, meets 
the recommendations of the Danish National Board of 
Health (maximum 14/21 drinks/week for women/men, 
with one drink containing 12 grams of pure alcohol). In 
the Relay Study, the primary outcome is the reduction of 
healthcare costs as an indirect indication that patients 
have reduced their alcohol consumption. In the Elderly 
Study, the primary outcome is abstinence or blood alco-
hol content  ≤ 0.5 at any given time.
 In all the studies, we have selected a significance level 
of α = 0.05, but we are clear to point out the differences 
between the interventions, and the control groups are 
large enough to affect whether alcohol therapists develop 
an interest in teaching and applying the new methods in 
daily practice. In a study, Miller and Manuel  [20] have 
demonstrated that healthcare providers are motivated to 
do this if there is a 10% increase in the proportion of pa-
tients who are abstinent or who reduce their alcohol con-
sumption to the above-mentioned recommendations. By 
continuous measures, the study showed that therapists 
would require a halving or doubling of outcome variables. 
We have chosen to adopt the results of the study and 
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made power calculations based on these, disseminating 
the results with an indication of those differences.
 For several of the studies, we have included cost-effec-
tiveness evaluations of the interventions, which may in-
fluence decision-makers in determining whether to im-
plement the developed interventions in practice.
 Treatment Processes (Training, Supervision, Manuals 
and Quality Control) 
 The experimental interventions in the studies are 
made as simple as possible. Staffs are trained in the inter-
vention method, typically by participating in a 2–5 days 
course, followed by supervision by an experienced project 
coordinator and expert in the experimental intervention. 
The core interventions in the studies are manualized in a 
very simple way as far as possible. In situations where it 
might be helpful, visual reminders such as brief scripts are 
developed for the staff, and written on ‘pocket cards’ that 
are easily accessible during the daily routine. That is the 
case in the Relay Study. When the interventions in the 
studies are particularly demanding and the need for uni-
formity in delivery crucial, the interventions are system-
atically recorded and regularly monitored by research 
staff. This is the case in the Self-match Study and the El-
derly Study. Monitoring the interventions by means of 
new technology is used when at all possible. This is the 
case in the Healthy Lifestyle Study by means of heart rate 
monitors, and in the Cue Exposure Study by means of a 
mobile application.
 Financial and Economics Evaluation 
 The financial costs associated with the implementa-
tion of the interventions in Danish health and social care 
are estimated in every case. Costs are estimated for a 
1-year period of the intervention, with cost models de-
signed to extrapolate to 5-year periods for financial plan-
ning, budgeting and priority setting. Almost all cost data 
are extracted from the Danish population registries at 
Statistics Denmark and health data. The health cost data-
base, in particular, providing unit, procedure and inter-
vention costs data at civil registration number levels, will 
be useful, enabling efficient and valid data collection both 
retrospectively for baseline cost data in all intervention 
groups and prospectively for pre- and post-intervention 
cost data collection in the various groups. Some specific 
programme cost data has to be collected ad hoc and some 
health and social care data has to be retrieved from local 
municipality registries. Cost differences between inter-
ventions are tested (bootstrapping tests with difference-
of-differences). For some interventions, for example, the 
Cue Exposure project, cost models are both more detailed 
and supplemented by cost-effectiveness analysis, relating 
cost differences to net changes in outcome parameters.
 Sample Size and Power Analysis 
 The size of each study has been determined based on 
the number of patients needed to ensure at least 80% 
power, in order to detect the relevant changes in the pri-
mary outcomes of each study when testing with a signifi-
cance level of 5%. For both the quantitative outcomes 
(Relay, Self-match and Healthy Lifestyle Studies) and the 
categorical outcomes (Elderly and Cue Exposure Stud-
ies), we used classical power calculation formulas to com-
pute the sample size, based on the desired value of power 
and detection of minimum relevant difference.
 Randomization and Statistical Analysis 
 For the Elderly, Self-match, Cue Exposure and Healthy 
Lifestyle Studies, we employ an urn design when random-
izing patients to treatment groups  [21] . The urn design 
forces small-sized trials to be balanced but approaches 
complete randomization as the trial’s enrolment pro-
gresses. This will not only allow us to obtain realistic re-
sults from small samples but ensures that the randomiza-
tion is less vulnerable to experimental bias compared to 
more classical randomization procedures. Studies across 
multiple centers are randomized within each center such 
that treatments appear as homogeneous as possible across 
centers and/or countries. For the Relay Study, a conven-
tional complete randomization procedure was used.
 The statistical analyses of the data will vary greatly 
from study to study since there are substantial differences 
in the experimental designs, available data and hypothe-
ses across the studies. Generally, however, regression 
modeling (including multiple linear modeling, logistic 
regression modeling and random effect/generalized lin-
ear mixed modeling) will be used to analyze the data and 
to correct for potential confounding. In all tests, α = 0.05 
will be chosen as the level of significance.
 Summary of the RESCueH Studies 
 The RESCueH studies are set to run over a 6-year pe-
riod and will be coordinated by UCAR. Set out below are 
brief summaries of the individual studies, which will be 
or have been submitted to the ClinicalTrials.gov Protocol 
Registration System, where more detailed descriptions 
are available.  Table 1 summarizes each study’s evaluation 
instruments.
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 The Relay Study – Recruiting Patients to Treatment 
 We need better strategies to ensure that patients with 
AUD receive the necessary treatment for their condition. 
Greater use of specialized treatment for alcohol depen-
dence needs to be a key element in society’s response to 
alcohol problems and its consequences.
 General hospitals are an obvious place to identify in-
dividuals for treatment of AUD since the condition is 
highly prevalent among inpatients  [22] . Departments of 
gastroenterology, neurology and orthopedic surgery have 
the highest prevalence  [23] .
 Patient contracts and reinforcement strategies are 
some of the more promising low-cost interventions for 
increasing participation in outpatient treatment. Only 
few studies have assessed these strategies, however. The 
Relay Study will test a new model for patient referral  [24] . 
It is a multicenter study involving hospitals in both urban 
and rural areas and will be conducted in hospital depart-
ments that have a high number of patients with AUD.
 In the experimental intervention (the Relay Model), a 
therapist from the alcohol treatment clinic meets the pa-
tient before discharge, and either gives advice about low-
ering alcohol intake or explains the importance of con-
tinuing outpatient aftercare and presents an ‘attendance 
contract’, depending on whether the patient scores  ≥ 8 or 
 ≥ 16 on the Audit Alcohol Use Identification Test  (AUDIT) 
 [23] . This contract includes information about the prog-
nosis for alcohol disorders and options for attending out-
patient care. The patient is given an appointment at the 
alcohol treatment clinic.
 Referral As Usual – in the standard intervention – the 
patient is encouraged to lower drinking and/or seek treat-
ment for AUD after discharge.
 In a randomized controlled design, the Relay Model 
will be compared with Referral as Usual over a follow-up 
period of 1 year. A total of 1,000 consecutive patients ad-
mitted to the departments of gastroenterology, neurology 
and orthopedic surgery at Odense University Hospital 
(urban area) and Aabenraa Hospital, Sønderjylland (rural 
area), who screen positive for AUDs using the AUDIT 
 [23] will be enrolled in the study. The primary outcome 
comprises the healthcare costs and social welfare costs in 
the year following the intervention. The secondary out-
come is the number of patients beginning specialized 
treatment for AUD after discharge from the general hos-
pital. Data will be collected from registers and databases 
and merged using the Danish Civil Registration System 
 [25] .
 Enrolment of patients in the study started October 
2013, and most patients have been willing to participate. Do
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We will, however, not reach 1,000 patients due to mainly 
re-organization at the hospitals. We expect to reach 700 
patients in June 2016, when enrolment will be concluded. 
Preliminary results suggest that approximately 12% of the 
patients on the participating departments have risky al-
cohol use (AUDIT score 8–15) in addition to 6% of the 
patients who screen positive for alcohol dependence 
(AUDIT score at  ≥ 16).
 The Elderly Study – Individualized Treatment 
 We need to provide a better service to specific patient 
groups. Elderly patients constitute a new and rapidly 
growing group that has quite different needs to other 
groups. No specific treatment targeted toward elderly pa-
tients is currently available. Consequently, these patients 
either receive no treatment or are given only brief advice 
from a general practitioner or are referred to treatment at 
specialized treatment institutions that lack specific expe-
rience with this patient group.
 Elderly patients are often lonely or have feelings of 
loss, are afraid of being a burden on their children and on 
society, and often feel powerless. On the surface, their al-
cohol-related problems may appear less severe than those 
of younger patients, but comorbidity and social issues 
complicate their alcohol dependency. The Elderly Study 
 [26] aims to improve the prognosis for this patient group 
by tailoring treatment to match individual needs.
 This multicenter study is designed as a randomized 
controlled trial with 2 arms and will be conducted in 3 
different drinking cultures. We aimed for enrolling a total 
of 1,000 consecutive patients, aged ≥60 years, seeking 
treatment for AUDs at 3 facilities in Denmark (Odense, 
Aarhus and Copenhagen – 400 patients), 2 facilities in 
Germany (Dresden and Munich – 400 patients) and a sin-
gle treatment facility in US (Albuquerque – 200 patients) 
in the study. The patients were randomized to either of 
the following:
 Brief Intervention, which comprises 4 sessions of Mo-
tivational Enhancement Therapy over 4 weeks. This in-
tervention is likely to be similar to that typically offered 
in general practice, or possibly to the intervention offered 
at specialized treatment centers, which lack experience 
with this patient group. The intervention in this arm is 
considered to be basic care.
 Brief Intervention plus adjusted Community Rein-
forcement Approach (CRA-Senior), which is the experi-
mental intervention and comprises the same 4 sessions of 
Motivational Enhancement Therapy over 4 weeks, fol-
lowed by 8 sessions of CRA-Senior. The CRA-Senior en-
courages sobriety by helping the patient create routines 
and activities that are meaningful to the patient and re-
ward staying sober. Particular focus is given to establish-
ing sober social networks.
 All patients will be interviewed at treatment start 
(baseline), after 4 weeks, 12 weeks, 6 months and 12 
months using structured interview instruments ( table 1 ).
 Enrolment of patients in the study started from  January 
2014. We reached >700 patients in May 2016, where en-
rollment was concluded. The initial power calculation 
was based on a power of 0.9, and with the actual number 
reached the power is 0.8, which is acceptable. It has been 
rather easy to recruit patients from Denmark and US, but 
more difficult in Germany. Baseline data from the first 
year of enrolment indicate that the elderly seeking treat-
ment for AUD are relatively well-educated and have a 
stable economy.
 The Self-Match Study – Involving Patients in 
Treatment Decisions 
 The choice of treatment for alcohol dependence is tra-
ditionally based on expert opinion. The few studies as-
sessing these expert-led management decisions suggest 
that they are little better than chance in ensuring that a 
patient receives the most appropriate treatment. How 
then, can we better determine the most relevant treat-
ment for an individual patient?
 One option is to allow patients to make an informed 
choice from a menu of evidence-based treatment options, 
and thus ‘match’ themselves with the treatment. Two ar-
guments support this. First, patients will choose options 
that are most likely to be acceptable or attractive to them, 
which is important for a process that aims to change peo-
ple’s behavior. Second, the ability to choose one’s own 
course of action is likely to increase motivation. The Self-
match Study will be the first of its kind to investigate the 
effects of ‘self-matching’ treatment for alcohol disorders 
versus assignment by a clinical expert.
 The study is a randomized controlled study with 2 
arms: (A) an experimental arm, involving patient self-
matching to treatment, and (B) TAU, involving expert 
assignment to treatment. A total of 400 consecutive pa-
tients aged 18–60 years, who either at presentation or af-
ter detoxification wish to start treatment at the Alcohol 
Treatment Clinic in Odense, will be enrolled. The pa-
tients will be interviewed at baseline and 6 months after 
treatment start.
 The study will start enrolment of patients in 2017. As 
part of the preparation of the information material to be 
used in study, a survey has been carried out among treat-
ment seekers in Danish alcohol treatment institutions 
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and published. The survey investigated what information 
about treatment the patients regarded to be important to 
have before starting the treatment  [27]. 
 The Cue Exposure Study – Preventing Relapse after 
Treatment 
 Alcohol-dependent patients typically avoid alcohol 
while they are in treatment, but a significant number of 
patients relapse to drinking after discharge. One reason 
for relapse is that society constantly exposes the patient 
to alcohol, which induces craving symptoms.
 During treatment, patients learn methods to identify 
high-risk situations for relapse to drinking, just as they 
learn strategies to avoid or tackle those situations. How-
ever, they learn by talking about what to do or not by actu-
ally trying the strategy out in real life which is likely to be 
more challenging. All too often, patients relapse when they 
face a high-risk situation in daily life, and it is only after-
ward that they can analyze and describe what went wrong. 
The question is whether we can improve the alcohol avoid-
ance strategies that patients use in daily life situations.
 The Cue Exposure Study will compare aftercare based 
on cue exposure delivered either by a therapist or through 
a smartphone application with standard aftercare, with 
the aim of preventing relapse to harmful drinking  [28] . 
The rationale of cue exposure treatment is that real-life 
training in safe settings will give the patient greater con-
fidence when exposed to alcohol outside the treatment 
institution, and may in the long-term even diminish reac-
tions to alcohol exposure.
 The study is a randomized controlled trial with 3 arms, 
of which 2 are experimental: (A) an experimental after-
care comprising 4 group sessions of cue exposure treat-
ment (1 session every 2 weeks), (B) an experimental after-
care comprising 1 individual session with instruction for 
a smartphone application + 1 individual follow-up ses-
sion 8 weeks after discharge and (C) aftercare as usual 
comprising 1 individual follow-up session 8 weeks after 
discharge, that is, no cue exposure treatment. A total of 
300 consecutive patients aged 18–60 years, who finish 
standard treatment at the Alcohol Treatment Center in 
Odense, will be enrolled in the study. The patients will be 
interviewed at baseline just before aftercare treatment 
and at 8 and 26 weeks after initiation of aftercare. Data 
collection will include relevant questionnaires and inter-
view instruments.
 Enrolment of patients in the study started from May 
2016, and currently 66 patients have been enrolled. Inter-
est in participating in the study is high. We expect to con-
tinue enrolling patients until early 2017.
 The Healthy Lifestyle Study – It Is Not Enough to Just 
Remove Alcohol 
 We need to widen the focus in treatment for AUD. 
Physical exercise is known to produce health-related ben-
efits for different patient groups and has a positive effect 
on physical, psychological and social aspects of alcohol 
abuse. Physical exercise can be used both as early preven-
tion and as part of a continuous treatment process.
 Exercise can help in problem drinking via several 
mechanisms. Moderate exercise can decrease the urge to 
drink. Exercise can offer positive alternatives to alcohol 
by providing pleasurable states through dopaminergic re-
inforcement. Exercise also improves psychosocial out-
comes in the form of mood management and reduces de-
pression and anxiety. Resilience factors, such as individ-
ual and social resources (e.g., self-confidence), are 
strengthened by regular physical activity, especially as a 
group activity.
 Physical exercise is a relatively new but promising 
treatment option in substance abuse. The Healthy Life-
style Study  [29] will test whether the addition of moderate 
physical training to standard treatment for alcohol de-
pendency will increase compliance with alcohol treat-
ment. Despite the potential benefit of exercise interven-
tions, only few studies have tested the impact of exercise 
as an adjunct to alcohol treatment. The findings from 
these studies suggest a positive relationship between ex-
ercise and drinking outcome, but the studies have meth-
odological limitations such as small samples, high drop-
out rate or lack of randomization.
 The study is a randomized controlled trial with 3 arms: 
(A) standard treatment + physical exercise on an indi-
vidual basis, (B) standard treatment + physical exercise in 
groups or (C) standard treatment alone. The exercise pro-
gramme will be conducted 2 days a week for a total of 24 
weeks. The programme consists of brisk walking or run-
ning, where the duration and intensity of the exercise in-
creases each week as the patients’ fitness level improves.
 We aimed for a total of 300 consecutive patients, aged 
18–60 years, presenting to the Alcohol Treatment Center 
in Odense to be enrolled in the study. The patients are 
interviewed and tested at baseline, and after 6 and 12 
months.
 All patients receive standard outpatient treatment at 
the Alcohol Treatment Center. This treatment comprises 
individual sessions with motivational interviewing (at the 
start of treatment), followed by cognitive behavioral ther-
apy and family therapy if appropriate.
 Enrolment of patients in the study began in May 2013, 
and was concluded in April 2015. One hundred seventy-
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five patients were enrolled in the study. All data, includ-
ing follow-up data, have been collected, and the analysis 
has begun. Findings of the study are expected to be pub-
lished later this year.
 Program Schedule 
 UCAR is responsible for implementing the RESCueH 
programme. UCAR has an established record of conduct-
ing alcohol treatment research of high clinical relevance. 
The RESCueH programme will be carried out in active 
treatment environments, that is, alcohol treatment clinics 
and hospital departments. The timetable for implement-
ing the RESCueH programme is shown in  figure 1 .
 Expected Results and Perspectives 
 In the Relay Study, we expect healthcare costs during 
the 12 months after hospital discharge to be significantly 
lower in the experimental group than in the standard re-
ferral group. We also expect that the number of patients 
initiating treatment at the specialized treatment clinic 
within 2 weeks after discharge will be higher in the ex-
perimental Relay Model than in the control group.
 If the new referral approach is found to be successful, 
it is likely that the intervention could be implemented 
more widely.
 The elderly patients assigned to a brief motivational 
intervention followed by a programme to enhance the 
quality of life and pleasure from sober living will have 
significantly reduced alcohol consumption and health-
care use at follow-up, compared to patients assigned the 
brief motivational intervention alone. It is hypothesized 
that these findings will be similar across drinking cul-
tures.
 If the brief motivational intervention plus CRA-Senior 
intervention is more successful than motivational inter-
vention alone, the approach will be recommended to cli-
nicians in specialized alcohol treatment institutions. 
Should the brief motivational intervention alone be as 
good as the extended intervention, it will be recommend-
ed for use in other settings, such as general practice or 
somatic hospitals. Besides improving treatment for AUDs 
among the elderly, we expect this study to make a signifi-
cant contribution to a better understanding of the inter-
pretation and comparison of study results from different 
countries.
 In the Self-match Study, we expect that patients who 
choose their own treatment method will drink significant-
ly less alcohol 1 year after treatment initiation than those 
who are assigned treatment by a clinical expert. We hy-
pothesize that this will be due to improved adherence to 
the treatment programme among self-matched patients.
 This study will contribute to knowledge about how to 
involve the patient in treatment, with the aim of improv-
ing adherence with treatment. If self-matching of treat-
ment proves to be successful, it will be a useful strategy 
for clinicians. It would require a more collaborative ap-
proach to working with patients, but should not impose 
extra costs.
 In the Cue Exposure Study, we expect that alcohol con-
sumption 8 and 26 weeks after discharge from treatment 
will be lower in the experimental groups (A and B) than 
in the control group (C). We also expect that the smart-
phone intervention will be more cost-effective than the 
other interventions.
 Besides increasing our knowledge about the effective-
ness of various methods of aftercare, this study will be the 
first in a series to incorporate new technology that will 
give the patient ready access to learned strategies in daily 
life after discharge. Such technology-based strategies are 
likely to be particularly useful for younger patients.
RESCueH 2013 2014 2015 2016 2017 2018 2019
Relay Study (data collection and analysis)
Elderly Study (data collection and analysis)
Self-match Study (data collection and analysis)
Cue Exposure Study (data collection and analysis)
Healthy Lifestyle Study (data collection and analysis)
Management of RESCueH
Dissemination of findings
 Fig. 1. The timetable for implementing the RESCueH programme. 
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 In the Healthy Lifestyle Study, we expect that alcohol 
consumption 6 months after starting the treatment will 
be lower in the experimental groups than in the control 
group. We also expect compliance during treatment to be 
better in the experimental groups than in the control 
group. Furthermore, we expect less anxiety and depres-
sion and better fitness in the experimental groups than in 
the control group.
 If a physical exercise programme proves to be benefi-
cial in the treatment of alcohol problems, it will be recom-
mended to clinicians in the alcohol treatment field as a 
low-cost strategy to improve the outcome of treatment. 
The study is expected to be followed up by further studies 
using other kinds of physical activity and by nutrition 
studies.
 Discussion 
 If you want to ensure an improved treatment of people 
with AUD in everyday practice, we believe there is a need 
for a research strategy which seeks to bridge the gap be-
tween efficacy trials and effectiveness trials. In 5 studies 
of the RESCueH programme, we have sought to combine 
features from the 2 designs with the main objective being 
to develop methods which in daily life ensure a better 
treatment for so many AUD patients representative of ev-
eryday clinical practice.
 Scientific Implications 
 We expect the findings of the RESCueH programme 
to make a significant contribution to the body of knowl-
edge about treatment for AUDs. The programme will also 
provide information of a more general nature that will 
extend much further than the specific research questions 
studied. The Elderly Study will allow us to study differ-
ences between US and European findings, which will in 
turn help us to interpret results from previous and future 
treatment studies.
 The findings of the RESCueH programme are expect-
ed to lead to a new generation of studies. A positive out-
come in the Healthy Lifestyle Study will stimulate further 
studies on aspects of patient lifestyle, such as nutrition. 
Successful recruitment strategies in the Relay Study will 
generate studies testing implementation of similar strate-
gies in other settings, such as general practice. A positive 
outcome in the Self-match Study may result in further 
investigation of patient empowerment and involvement 
in treatment, such as consideration of subjective experi-
ences from drinking alcohol. Successful strategies for pre-
venting relapse in the Cue Exposure Study are likely to 
inspire further research into the use of new technologies 
in controlling craving and in the treatment of AUDs more 
generally.
 Clinical Implications 
 The RESCueH research programme addresses specific 
clinical problems in the treatment of AUDs. The studies 
will be conducted in active treatment settings, and the re-
sulting new methods and approaches should be feasible 
to implement in these settings. The participation of the 2 
largest Danish public alcohol treatment institutions in-
creases the likelihood that the interventions will be imple-
mented if they prove effective. Dissemination of study 
findings will be further aided by the close dialogue that 
the Unit for Clinical Alcohol Research has with the Dan-
ish Network of Alcohol Treatment Institution Managers.
 Ethics 
 In all the studies, the patients will receive oral and writ-
ten information. It will be emphasized that declination of 
participation will not in any way have an impact on sub-
sequent treatment offered to the patient. Likewise, accep-
tance of participation can at any point in time be with-
drawn, again with no impact on the treatment offered.
 No information is collected before the patient has ac-
cepted participation by an informed consent declaration.
 All information obtained in the study will be dealt with 
confidentially. Participants will be allocated a respondent 
number. No analysis or publications will contain any in-
formation that can identify any individual patient.
 Data collected in the study will be stored locally. Each 
center will ensure data quality and data security accord-
ing to guidelines across centers. Furthermore, all data 
management must apply with all local guidelines and reg-
ulations, which may differ from center to center.
 Adverse events will be handled according to local 
guidelines as specified for each participating center, 
which again may differ from center to center, but will not 
differ from how any other adverse event is handled at that 
particular center.
 The Elderly Study, the Cue Exposure Study and the 
Healthy Lifestyle Study have been approved by the local 
ethics committees. The Relay Study has been presented to 
the local Ethics Committee who decided that the study 
did not need approval. The Self-match Study will be ap-
proved by the local Ethics Committee before initiation. 
All guidelines for data protection are followed. All proce-
dures in the study are in accordance with the second Dec-
laration of Helsinki.
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